Insider Transactions in Q4 2025 at Rapport Therapeutics, Inc. (RAPP)

Date	Insider	Transaction	Ownership Type	Shares Traded	Value / Price
Dec 17 2025	Abraham Ceesay Chief Executive Officer	SELL Open market or private sale	Indirect	5,083 -4.92%	$147,407 $29.97 P/Share
Dec 17 2025	Abraham Ceesay Chief Executive Officer	SELL Open market or private sale	Direct	5,833 -0.34%	$169,157 $29.97 P/Share
Dec 15 2025	David Bredt Chief Scientific Officer	SELL Open market or private sale	Direct	8,500 -1.06%	$255,000 $30.32 P/Share

Nov 26 2025	Cheryl Gault Chief Operating Officer	SELL Open market or private sale	Direct	5,000 -2.83%	$150,000 $30.1 P/Share
Nov 26 2025	Cheryl Gault Chief Operating Officer	BUY Exercise of conversion of derivative security	Direct	5,000 +2.75%	$5,000 $1.8 P/Share
Nov 17 2025	David Bredt Chief Scientific Officer	SELL Open market or private sale	Direct	8,500 -1.04%	$212,500 $25.12 P/Share
Nov 17 2025	Abraham Ceesay Chief Executive Officer	SELL Open market or private sale	Indirect	5,083 -6.39%	$127,075 $25.18 P/Share
Nov 17 2025	Abraham Ceesay Chief Executive Officer	SELL Open market or private sale	Direct	5,833 -0.5%	$145,825 $25.18 P/Share
Oct 15 2025	Abraham Ceesay Chief Executive Officer	SELL Open market or private sale	Indirect	5,083 -5.59%	$127,075 $25.96 P/Share
Oct 15 2025	Abraham Ceesay Chief Executive Officer	SELL Open market or private sale	Direct	5,833 -0.5%	$145,825 $25.93 P/Share
Oct 15 2025	David Bredt Chief Scientific Officer	SELL Open market or private sale	Direct	8,500 -1.02%	$212,500 $25.95 P/Share

Receive a notification when an Institution or Guru buys or sells RAPP shares.

Notify only if

Value

Get notified when an Rapport Therapeutics, Inc. insider buys or sells RAPP shares.

Notify only if

Operation

Value

Type

Receive news related to Rapport Therapeutics, Inc.